Rosanne S.
- Country
- Germany
- Department
- Klinik I für Innere Medizin
Research Overview
- An interventional efficacy and safety Phase 3 double-blind 2-arm study to investigate IV followed by oral fosmanogepix compared with IV caspofungin followed by oral fluconazole in adult participants with candidemia and/or invasive candidiasis.
- Evaluation of Rezafungin Acetate for Chronic Pulmonary Aspergillosis in Patients with Limited Treatment Options: A Phase 2, Open-Label Study
Data & Insights
Has run more than one trial at 7 of 62 partner sites.
Specializations
Fungal Infections
This investigator specializes in treating severe fungal infections, with particular expertise in candidemia and invasive candidiasis. Their research focuses on developing therapeutic solutions for these potentially life-threatening conditions.
- Bloodstream Infections
- Systemic Candida Infections
- Antifungal Therapeutics
The investigator explores innovative treatment approaches combining intravenous and oral antifungal medications.
Critical Care Medicine
Their expertise extends to managing severe infections in critical care settings, focusing on systemic fungal diseases that affect immunocompromised patients.
- Intensive Care Treatment Protocols
- Management of Severe Infections
- Critical Care Interventions
The investigator evaluates therapeutic strategies for patients requiring intensive medical intervention.
Therapeutic Innovation
The investigator studies novel antifungal agents and treatment regimens for invasive fungal infections, comparing emerging therapies with established treatment standards.
- Novel Antifungal Compounds
- Treatment Optimization
- Clinical Efficacy Assessment
Their work encompasses evaluation of new therapeutic options against conventional treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.